Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Reata Pharmaceuticals, Inc. Recruiting
2
Trial Phase
210
Trial Size
1.96 2 miles
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis Mallinckrodt Recruiting
4
Trial Phase
232
Trial Size
1.96 2 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
1.96 2 miles
Evidence Amyloid Scan EEG Study Metabolic Therapy Inc. Recruiting N/A
2000
Trial Size
2.86 3 miles
A Phase 2 Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) Velicept Therapeutics, Inc. Recruiting
2
Trial Phase
1200
Trial Size
3.11 3 miles
Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET Radiomedix, Inc. Recruiting
1
Trial Phase
50
Trial Size
3.62 4 miles
Health and Wellness in Healthcare Providers Post-disaster University of Illinois at Urbana-Champaign Recruiting N/A
800
Trial Size
3.88 4 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
4.64 5 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
4.64 5 miles
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study Pfizer Recruiting
3
Trial Phase
500
Trial Size
6.37 6 miles
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate Pfizer Available
3
Trial Phase
0
Trial Size
6.48 6 miles
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma M.D. Anderson Cancer Center Recruiting
2
Trial Phase
64
Trial Size
6.48 6 miles
Midostaurin Access Program for Newly Diagnosed FLT3 Mutated AML Patients Eligible for Standard Induction Novartis Available N/A
0
Trial Size
6.48 6 miles
Robotic Versus Laparoscopic Ventral Hernia Repair The University of Texas Health Science Center, Houston Recruiting N/A
120
Trial Size
6.48 6 miles
Efficacy of a Two-Year Intensive Reading Intervention for Middle School English Learners With Reading Difficulties University of Houston Recruiting N/A
840
Trial Size
6.48 6 miles
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) Genentech, Inc. Recruiting
2
Trial Phase
270
Trial Size
7.60 8 miles
Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens [Redacted] Recruiting
2
Trial Phase
510
Trial Size
8.59 9 miles
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants Pfizer Recruiting
2
Trial Phase
460
Trial Size
8.59 9 miles
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea AOBiome LLC Recruiting
2
Trial Phase
130
Trial Size
8.59 9 miles
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia Pharmacyclics Recruiting N/A
1500
Trial Size
8.83 9 miles
Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT) The Methodist Hospital System Recruiting
2
Trial Phase
47
Trial Size
8.83 9 miles
Olive Oil for Breast Cancer Prevention in Women at High Risk for Breast Cancer The Methodist Hospital System Recruiting N/A
100
Trial Size
8.83 9 miles
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension Allergan Recruiting
3
Trial Phase
600
Trial Size
9.26 9 miles
Feasibility of Healthy Dads Healthy Kids Latino Baylor College of Medicine Recruiting N/A
160
Trial Size
9.26 9 miles
A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye Dompé Farmaceutici S.p.A Recruiting
2
Trial Phase
300
Trial Size
9.26 9 miles
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Shire Recruiting
3
Trial Phase
264
Trial Size
10.53 11 miles
Coaching and Education for Diabetes Distress Baylor College of Medicine Recruiting N/A
156
Trial Size
10.53 11 miles
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU Novartis Recruiting
2
Trial Phase
360
Trial Size
10.53 11 miles
Cognitive Remediation for Cocaine Dependence The University of Texas Health Science Center, Houston Recruiting
2
Trial Phase
200
Trial Size
10.60 11 miles
HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN) University of Utah Recruiting N/A
1400
Trial Size
11.31 11 miles
Selecting a Favorable KIR Donor in Unrelated HCT for AML Masonic Cancer Center, University of Minnesota Recruiting N/A
800
Trial Size
11.31 11 miles
Multimodal Therapy for the Treatment of Sleep Disturbance in Patients With Advanced Cancer M.D. Anderson Cancer Center Recruiting
2
Trial Phase
64
Trial Size
11.31 11 miles
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma Celgene Corporation Available N/A
0
Trial Size
11.31 11 miles
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 Dana-Farber Cancer Institute Recruiting
3
Trial Phase
660
Trial Size
11.31 11 miles
Connect® MM- The Multiple Myeloma Disease Registry Celgene Corporation Recruiting N/A
3000
Trial Size
11.31 11 miles
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients APT Pharmaceuticals, Inc. Available N/A
0
Trial Size
11.31 11 miles
Double Cord Versus Haploidentical (BMT CTN 1101) Medical College of Wisconsin Recruiting
3
Trial Phase
410
Trial Size
11.31 11 miles
Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection Gilead Sciences Recruiting
3
Trial Phase
100
Trial Size
11.31 11 miles
Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients Baylor Breast Care Center Recruiting
2
Trial Phase
153
Trial Size
11.31 11 miles
Genomic Testing for Primary Breast Cancer M.D. Anderson Cancer Center Recruiting N/A
1100
Trial Size
11.31 11 miles
Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II M.D. Anderson Cancer Center Recruiting N/A
130
Trial Size
11.31 11 miles
Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access Biomet, Inc. Available N/A
0
Trial Size
11.31 11 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
11.31 11 miles
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy Pfizer Available
4
Trial Phase
0
Trial Size
11.31 11 miles
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) M.D. Anderson Cancer Center Recruiting
2
Trial Phase
80
Trial Size
11.31 11 miles
Yoga Program for Lung Cancer Patients and Caregivers M.D. Anderson Cancer Center Recruiting N/A
100
Trial Size
11.31 11 miles
Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients Arog Pharmaceuticals LLC Recruiting
2
Trial Phase
48
Trial Size
11.31 11 miles
Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients Arog Pharmaceuticals LLC Recruiting
1
Trial Phase
88
Trial Size
11.31 11 miles
Active Surveillance in Prostate Cancer M.D. Anderson Cancer Center Recruiting N/A
1000
Trial Size
11.31 11 miles
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
3
Trial Phase
800
Trial Size
11.31 11 miles
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease The University of Texas Health Science Center, Houston Recruiting
3
Trial Phase
1300
Trial Size
11.31 11 miles
A Multi-Center Trial of the ProLung Testâ„¢ Fresh Medical Laboratories Recruiting N/A
300
Trial Size
11.31 11 miles
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes BioMed Valley Discoveries, Inc Recruiting
1
Trial Phase
60
Trial Size
11.31 11 miles
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection Seres Health Inc Available
2
Trial Phase
29
Trial Size
11.31 11 miles
Longitudinal Study of Urea Cycle Disorders Office of Rare Diseases (ORD) Recruiting
2
Trial Phase
1100
Trial Size
11.31 11 miles
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE) Edwards Lifesciences Recruiting N/A
1025
Trial Size
11.31 11 miles
Carfilzomib Plus Panobinostat in Relapsed/Refractory Multiple Myeloma (MM) M.D. Anderson Cancer Center Recruiting
1
Trial Phase
66
Trial Size
11.31 11 miles
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) M.D. Anderson Cancer Center Recruiting
2
Trial Phase
84
Trial Size
11.31 11 miles
Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL) M.D. Anderson Cancer Center Recruiting
1
Trial Phase
146
Trial Size
11.31 11 miles
A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma M.D. Anderson Cancer Center Recruiting
3
Trial Phase
205
Trial Size
11.31 11 miles
A Prospective Phase III Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy M.D. Anderson Cancer Center Recruiting
3
Trial Phase
100
Trial Size
11.31 11 miles
A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms M.D. Anderson Cancer Center Recruiting
3
Trial Phase
300
Trial Size
11.31 11 miles
Pilot Tests to Optimize the Delivery of Energy Balance Interventions M.D. Anderson Cancer Center Recruiting N/A
240
Trial Size
11.31 11 miles
Third-Party Cytotoxic T-Lymphocytes (CTLs) for Cytomegalovirus (CMV) Infection M.D. Anderson Cancer Center Recruiting
2
Trial Phase
30
Trial Size
11.31 11 miles
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 Isis Pharmaceuticals Recruiting
1
Trial Phase
80
Trial Size
11.31 11 miles
Imaging Biomarkers in Pancreatic Cancer M.D. Anderson Cancer Center Recruiting N/A
259
Trial Size
11.31 11 miles
Physician Perceptions About Parenteral Hydration in Latin America and Spain M.D. Anderson Cancer Center Recruiting N/A
516
Trial Size
11.31 11 miles
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas M.D. Anderson Cancer Center Recruiting
3
Trial Phase
200
Trial Size
11.31 11 miles
Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma M.D. Anderson Cancer Center Recruiting
1
Trial Phase
68
Trial Size
11.31 11 miles
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) M.D. Anderson Cancer Center Recruiting
2
Trial Phase
20
Trial Size
11.31 11 miles
Phase II Study of BMN 673 M.D. Anderson Cancer Center Recruiting
2
Trial Phase
270
Trial Size
11.31 11 miles
Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment Eligibility M.D. Anderson Cancer Center Recruiting N/A
120
Trial Size
11.31 11 miles
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome Children's Hospital of Philadelphia Recruiting
1
Trial Phase
15
Trial Size
11.31 11 miles
Spinal Stereotactic Body Radiation Therapy M.D. Anderson Cancer Center Recruiting N/A
57
Trial Size
11.31 11 miles
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients M.D. Anderson Cancer Center Recruiting
1
Trial Phase
42
Trial Size
11.31 11 miles
Scleroderma Registry National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Recruiting N/A
5000
Trial Size
11.31 11 miles
Chemoradiation-Induced Nausea and Emesis: Quality of Life M.D. Anderson Cancer Center Recruiting N/A
200
Trial Size
11.31 11 miles
Neoadjuvant Axitinib in Prostate Cancer M.D. Anderson Cancer Center Recruiting
2
Trial Phase
72
Trial Size
11.31 11 miles
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Academic Myeloma Consortium Recruiting
1
Trial Phase
117
Trial Size
11.31 11 miles
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Novartis Recruiting
3
Trial Phase
420
Trial Size
11.31 11 miles
A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions The University of Texas Health Science Center, Houston Recruiting N/A
1000
Trial Size
11.31 11 miles
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Southwest Oncology Group Recruiting
3
Trial Phase
1900
Trial Size
11.31 11 miles
Oral TRK Inhibitor LOXO-101 for Treatment of Advanced Adult Solid Tumors Loxo Oncology, Inc. Recruiting
1
Trial Phase
108
Trial Size
11.31 11 miles
BBD Longitudinal Study of Osteogenesis Imperfecta Baylor College of Medicine Recruiting N/A
1000
Trial Size
11.31 11 miles
Integrated Stepped Care for Unhealthy Alcohol Use in HIV Yale University Recruiting N/A
642
Trial Size
11.31 11 miles
A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE) OncoMed Pharmaceuticals, Inc. Recruiting
1
Trial Phase
80
Trial Size
11.31 11 miles
Biomarker Guided Therapies in Stage A/B Heart Failure Department of Veterans Affairs Recruiting
2
Trial Phase
210
Trial Size
11.31 11 miles
Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children Baylor College of Medicine Recruiting
1
Trial Phase
18
Trial Size
11.31 11 miles
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry Monteris Medical Recruiting N/A
300
Trial Size
11.31 11 miles
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint Agendia Recruiting N/A
1200
Trial Size
11.31 11 miles
Artisan Aphakia Lens for the Correction of Aphakia in Children Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
11.31 11 miles
Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL Baylor College of Medicine Recruiting
1
Trial Phase
44
Trial Size
11.31 11 miles
NSABP Biospecimen Discovery Project National Surgical Adjuvant Breast and Bowel Project (NSABP) Recruiting N/A
50
Trial Size
11.31 11 miles
Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC) M.D. Anderson Cancer Center Recruiting
2
Trial Phase
40
Trial Size
11.31 11 miles
A Study of LY3164530 in Participants With Cancer Eli Lilly and Company Recruiting
1
Trial Phase
45
Trial Size
11.31 11 miles
Informal Caregivers ANSWERS Department of Veterans Affairs Recruiting N/A
330
Trial Size
11.31 11 miles
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Vanderbilt-Ingram Cancer Center Recruiting
1
Trial Phase
74
Trial Size
11.31 11 miles
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
30
Trial Size
11.31 11 miles
SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) Biotie Therapies Inc. Recruiting
2
Trial Phase
80
Trial Size
11.31 11 miles
MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC) M.D. Anderson Cancer Center Recruiting
2
Trial Phase
35
Trial Size
11.31 11 miles
Scleroderma Treatment With Autologous Transplant (STAT) Study Fred Hutchinson Cancer Research Center Recruiting
2
Trial Phase
30
Trial Size
11.31 11 miles
Personalized Cancer Therapy M.D. Anderson Cancer Center Recruiting N/A
8000
Trial Size
11.31 11 miles
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension Arbor Pharmaceuticals, Inc. Recruiting
3
Trial Phase
260
Trial Size
11.31 11 miles
Development & Testing of a Decision Aid for LVAD Placement Baylor College of Medicine Recruiting N/A
144
Trial Size
11.31 11 miles
Cord Blood Natural Killer (NK) Cells in Chronic Lymphocytic Leukemia (CLL) M.D. Anderson Cancer Center Recruiting
1
Trial Phase
44
Trial Size
11.31 11 miles
PCORI-CER-1306-03385 Lung Cancer Screening Readiness Study M.D. Anderson Cancer Center Recruiting N/A
1000
Trial Size
11.31 11 miles
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation Oculeve, Inc. Recruiting N/A
35
Trial Size
11.31 11 miles
Functional Neuroimaging of Cortical Plasticity in the Human Visual System Baylor College of Medicine Recruiting N/A
200
Trial Size
11.31 11 miles
Survivorship in Lynch Syndrome Families M.D. Anderson Cancer Center Recruiting N/A
610
Trial Size
11.31 11 miles
Virtual Temporal Bone Surgery: Defining and Translating Metrics Nationwide Children's Hospital Recruiting
1
Trial Phase
170
Trial Size
11.31 11 miles
The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface Baylor College of Medicine Recruiting N/A
30
Trial Size
11.31 11 miles
High-Resolution Microendoscopy (HRME) of Cervix M.D. Anderson Cancer Center Recruiting N/A
20
Trial Size
11.31 11 miles
A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer M.D. Anderson Cancer Center Recruiting
1
Trial Phase
38
Trial Size
11.31 11 miles
Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies BeiGene Recruiting
1
Trial Phase
125
Trial Size
11.31 11 miles
Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy M.D. Anderson Cancer Center Recruiting
1
Trial Phase
45
Trial Size
11.31 11 miles
Liposomal Doxorubicin, Bevacizumab and Temsirolimus (DAT) in Triple-Negative Breast Cancer (TNBC) Insensitive to Standard Neoadjuvant Chemotherapy M.D. Anderson Cancer Center Recruiting
2
Trial Phase
37
Trial Size
11.31 11 miles
Quality Improvement Project - Evaluation of Current Standard of Care for Feeding Practices in the NICU Baylor College of Medicine Recruiting N/A
150
Trial Size
11.31 11 miles
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH) Department of Veterans Affairs Recruiting
2
Trial Phase
74
Trial Size
11.31 11 miles
Intensity-Modulated Scanning Beam Proton Therapy (IMPT) With Simultaneous Integrated Boost (SIB) M.D. Anderson Cancer Center Recruiting
1
Trial Phase
100
Trial Size
11.31 11 miles
Effect of Vitamin D in Diets of Preterm Infants Baylor College of Medicine Recruiting N/A
50
Trial Size
11.31 11 miles
The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO) AOSpine North America Research Network Recruiting N/A
350
Trial Size
11.31 11 miles
Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies Boston Strategics Corporation Recruiting
1
Trial Phase
56
Trial Size
11.31 11 miles
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury Baylor College of Medicine Available N/A
0
Trial Size
11.31 11 miles
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol M.D. Anderson Cancer Center Recruiting N/A
5000
Trial Size
11.31 11 miles
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies M.D. Anderson Cancer Center Recruiting
1
Trial Phase
120
Trial Size
11.31 11 miles
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up) Harvard School of Public Health Recruiting N/A
850
Trial Size
11.31 11 miles
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Children's Oncology Group Recruiting
1
Trial Phase
51
Trial Size
11.31 11 miles
Genomic Response Analysis of Heart Failure Therapy in African Americans University of Pittsburgh Recruiting N/A
500
Trial Size
11.31 11 miles
Prospective Study of Colon Serrated Polyps M.D. Anderson Cancer Center Recruiting N/A
10000
Trial Size
11.31 11 miles
Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome Baylor College of Medicine Recruiting
1
Trial Phase
30
Trial Size
11.31 11 miles
A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer Strategia Therapeutics Recruiting
1
Trial Phase
54
Trial Size
11.31 11 miles
Molecular-Guided Therapy for Childhood Cancer Spectrum Health Hospitals Recruiting N/A
56
Trial Size
11.31 11 miles
SynCardia 70cc TAH-t for Destination Therapy (DT) SynCardia Systems. Inc. Recruiting N/A
38
Trial Size
11.31 11 miles
Syncardia 50cc TAH-t as a Bridge to Transplant SynCardia Systems. Inc. Recruiting N/A
72
Trial Size
11.31 11 miles
High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull Massachusetts General Hospital Recruiting
2
Trial Phase
120
Trial Size
11.31 11 miles
Project 2: Strategies for Reducing Nicotine Content in Cigarettes University of Pittsburgh Recruiting
3
Trial Phase
1250
Trial Size
11.31 11 miles
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure Duke University Recruiting
2
Trial Phase
360
Trial Size
11.31 11 miles
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa Dana-Farber Cancer Institute Recruiting
2
Trial Phase
170
Trial Size
11.31 11 miles
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation M.D. Anderson Cancer Center Recruiting
2
Trial Phase
105
Trial Size
11.31 11 miles
Smartphone-Delivered Training for Smokers M.D. Anderson Cancer Center Recruiting N/A
750
Trial Size
11.31 11 miles
The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma Georgetown University Recruiting
2
Trial Phase
15
Trial Size
11.31 11 miles
Treatment Of Supracondylar Fractures Closed Reduction And Circular Ring External Fixation Versus Open Reduction and Internal Fixation Baylor College of Medicine Recruiting N/A
20
Trial Size
11.31 11 miles
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010MA in Advanced Non Small Cell Lung Cancer ACEA Biosciences, Inc. Recruiting
1
Trial Phase
100
Trial Size
11.31 11 miles
Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Recruiting N/A
600
Trial Size
11.31 11 miles
High-Flow Oxygen for Exertional Dyspnea M.D. Anderson Cancer Center Recruiting
2
Trial Phase
50
Trial Size
11.31 11 miles
Ipilimumab and Lenalidomide in Advanced Cancer M.D. Anderson Cancer Center Recruiting
1
Trial Phase
101
Trial Size
11.31 11 miles
A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome Opsona Therapeutics Ltd. Recruiting
1
Trial Phase
40
Trial Size
11.31 11 miles
Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A Baylor College of Medicine Recruiting
2
Trial Phase
40
Trial Size
11.31 11 miles
ARMS - Rapidly Generated Multivirus-Specific CTLs for the Prophylaxis And Treatment of EBV, CMV, Adenovirus, HHV6, and BK Virus Baylor College of Medicine Recruiting
1
Trial Phase
35
Trial Size
11.31 11 miles
Quality of Life Questionnaire for Pediatric Patients Undergoing Peritoneal Perfusion M.D. Anderson Cancer Center Recruiting N/A
40
Trial Size
11.31 11 miles
Phase II Study of Tipifarnib in Advanced Cancers With HRAS Mutations Kura Oncology, Inc. Recruiting
2
Trial Phase
36
Trial Size
11.31 11 miles
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas M.D. Anderson Cancer Center Recruiting N/A
40
Trial Size
11.31 11 miles
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection AIDS Clinical Trials Group Recruiting
1
Trial Phase
50
Trial Size
11.31 11 miles
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Associazione Angela Serra per la ricerca sul cancro Recruiting N/A
2000
Trial Size
11.31 11 miles
Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes The University of Texas Health Science Center, Houston Recruiting
2
Trial Phase
396
Trial Size
11.31 11 miles
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung ACORN Research, LLC Recruiting
2
Trial Phase
35
Trial Size
11.31 11 miles
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 Leading BioSciences, Inc Recruiting
2
Trial Phase
260
Trial Size
11.31 11 miles
Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma M.D. Anderson Cancer Center Recruiting N/A
56
Trial Size
11.31 11 miles
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Duke University Recruiting
2
Trial Phase
500
Trial Size
11.31 11 miles
Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery M.D. Anderson Cancer Center Recruiting
2
Trial Phase
80
Trial Size
11.31 11 miles
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia National Cancer Institute (NCI) Recruiting
3
Trial Phase
4895
Trial Size
11.31 11 miles
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
500
Trial Size
11.31 11 miles
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma Greater Houston Retina Research Recruiting N/A
100
Trial Size
11.31 11 miles
Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. Greater Houston Retina Research Recruiting
2
Trial Phase
40
Trial Size
11.31 11 miles
Pilot Project for Creation of the Diffuse Large B-cell Lymphoma (DLBCL) Response Prediction Model M.D. Anderson Cancer Center Recruiting N/A
50
Trial Size
11.31 11 miles
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders Baylor College of Medicine Recruiting
0
Trial Phase
20
Trial Size
11.31 11 miles
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy M.D. Anderson Cancer Center Recruiting N/A
500
Trial Size
11.31 11 miles
Exposure Therapy For Veterans With PTSD And Panic Attacks Department of Veterans Affairs Recruiting N/A
62
Trial Size
11.31 11 miles
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors GlaxoSmithKline Recruiting
1
Trial Phase
200
Trial Size
11.31 11 miles
Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated Cyberonics Recruiting N/A
600
Trial Size
11.31 11 miles
GSK1120212 Rollover Study GlaxoSmithKline Recruiting
2
Trial Phase
250
Trial Size
11.31 11 miles
Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema ImpediMed Limited Recruiting N/A
1100
Trial Size
11.31 11 miles
Fetal Endotracheal Occlusion (FETO) in Severe and Extremely Severe Congenital Diaphragmatic Hernia Utah HealthCare Institute Recruiting N/A
15
Trial Size
11.31 11 miles
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence National Institute on Drug Abuse (NIDA) Recruiting
1
Trial Phase
80
Trial Size
11.31 11 miles
Pentoxifylline Therapy in Biliary Atresia Baylor College of Medicine Recruiting
2
Trial Phase
60
Trial Size
11.31 11 miles
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects HumanOptics AG Recruiting
3
Trial Phase
460
Trial Size
11.31 11 miles
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation [Redacted] Recruiting N/A
192
Trial Size
11.31 11 miles
DOXAZOSIN FOR PTSD Baylor College of Medicine Recruiting
1
Trial Phase
30
Trial Size
11.31 11 miles
A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device Baylor College of Medicine Recruiting N/A
35
Trial Size
11.31 11 miles
Treatment of Hemoglobin SC Disease Baylor College of Medicine Recruiting
2
Trial Phase
41
Trial Size
11.31 11 miles
CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney Disease The Cleveland Clinic Recruiting N/A
526
Trial Size
11.31 11 miles
Carisbamate as a Potential Treatment for Alcohol Dependence Baylor College of Medicine Recruiting
1
Trial Phase
10
Trial Size
11.31 11 miles
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants Baylor College of Medicine Recruiting N/A
15
Trial Size
11.31 11 miles
Id-KLH Vaccine + T Cells Abramson Cancer Center of the University of Pennsylvania Recruiting
2
Trial Phase
30
Trial Size
11.31 11 miles
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 Pfizer Available N/A
0
Trial Size
11.31 11 miles
Expanded access study of fenretinide LYM-X-sorb plus ketoconazole in neuroblastoma South Plains Oncology Consortium Available N/A
0
Trial Size
11.31 11 miles
Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia Baylor College of Medicine Available N/A
0
Trial Size
11.31 11 miles
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy Marathon Pharmaceuticals, LLC Available N/A
0
Trial Size
11.31 11 miles
An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC M.D. Anderson Cancer Center Available N/A
0
Trial Size
11.31 11 miles
Study to Treat Major Depressive Disorder With a New Medication Icahn School of Medicine at Mount Sinai Recruiting
2
Trial Phase
48
Trial Size
11.31 11 miles
Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure Tenax Therapeutics, Inc. Available N/A
0
Trial Size
11.31 11 miles
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Spinal Cord Injury The University of Texas Health Science Center, Houston Recruiting N/A
15
Trial Size
11.31 11 miles
Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases M.D. Anderson Cancer Center Recruiting
2
Trial Phase
80
Trial Size
11.31 11 miles
Axicabtagene Ciloleucel Expanded Access Study Kite Pharma, Inc. Available N/A
0
Trial Size
11.31 11 miles
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors Genentech, Inc. Available N/A
0
Trial Size
11.31 11 miles
Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma Molecular Insight Pharmaceuticals, Inc. Available N/A
0
Trial Size
11.31 11 miles
ATTR Expanded Access Program (EAP) by Ionis Ionis Pharmaceuticals, Inc. Available N/A
0
Trial Size
11.31 11 miles
A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers Genentech, Inc. Recruiting
1
Trial Phase
449
Trial Size
11.31 11 miles
Development of Adaptive Deep Brain Stimulation for OCD Baylor College of Medicine Recruiting N/A
2
Trial Size
11.31 11 miles
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies M.D. Anderson Cancer Center Recruiting N/A
50
Trial Size
11.31 11 miles
Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation The University of Texas Health Science Center, Houston Recruiting N/A
16
Trial Size
11.31 11 miles
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) M.D. Anderson Cancer Center Recruiting N/A
452
Trial Size
11.31 11 miles
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies Shanghai Junshi Bioscience Co.,Ltd. Recruiting
1
Trial Phase
78
Trial Size
11.31 11 miles
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation The Methodist Hospital System Recruiting
2
Trial Phase
24
Trial Size
11.31 11 miles
Hyper-CVAD in Combination With Inotuzumab Ozogamicin as Frontline Therapy for Adults With Acute Lymphocytic Leukemia M.D. Anderson Cancer Center Recruiting
2
Trial Phase
60
Trial Size
11.31 11 miles
Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism Baylor College of Medicine Recruiting
4
Trial Phase
120
Trial Size
11.31 11 miles
Mycobiome Evaluation in Children With Autism & GI Symptoms The University of Texas Health Science Center, Houston Recruiting N/A
60
Trial Size
11.31 11 miles
Randomized, Prospective Comparison of Methods to Process Autologous Fat Grafts in Breast Reconstruction M.D. Anderson Cancer Center Recruiting N/A
110
Trial Size
11.31 11 miles
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension AB2 Bio Ltd. Recruiting
3
Trial Phase
10
Trial Size
11.31 11 miles
A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy Pfizer Recruiting
2
Trial Phase
220
Trial Size
11.31 11 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
11.31 11 miles
RACHEL1: Radiation and CHEckpoint bLockade Trial in Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer M.D. Anderson Cancer Center Recruiting
1
Trial Phase
20
Trial Size
11.31 11 miles
Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis Texas Woman's University Recruiting N/A
80
Trial Size
11.31 11 miles
Project Take Charge M.D. Anderson Cancer Center Recruiting N/A
50
Trial Size
11.31 11 miles
Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma The University of Texas Health Science Center, Houston Recruiting
1
Trial Phase
9
Trial Size
11.31 11 miles
Ponatinib + Venetoclax for Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) M.D. Anderson Cancer Center Recruiting
1
Trial Phase
38
Trial Size
11.31 11 miles
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors Genmab Recruiting
1
Trial Phase
188
Trial Size
11.31 11 miles
Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video Optinose US Inc. Recruiting
3
Trial Phase
10
Trial Size
11.31 11 miles
This Study is to Evaluate OBI-3424 Safe and Effective Treatment Dose in Subjects With Hepatocellular Carcinoma or Castrate Resistant Prostate Cancer OBI Pharma, Inc Recruiting
1
Trial Phase
92
Trial Size
11.31 11 miles
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM The Methodist Hospital System Recruiting
1
Trial Phase
62
Trial Size
11.31 11 miles
Study of BAY1834942 in Patients With Solid Tumors Bayer Recruiting
1
Trial Phase
206
Trial Size
11.31 11 miles
Chemotherapy and/or Metastasectomy in Treating Participants With Metastatic Colorectal Adenocarcinoma With Lung Metastases M.D. Anderson Cancer Center Recruiting
2
Trial Phase
365
Trial Size
11.31 11 miles
Clinical Trial of SP-2577 in Patients With Relapsed or Refractory Ewing Sarcoma Salarius Pharmaceuticals, LLC Recruiting
1
Trial Phase
50
Trial Size
11.31 11 miles
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Klus Pharma Inc. Recruiting
1
Trial Phase
82
Trial Size
11.31 11 miles
Post Market Clinical Follow-up Study of the REDAPT Monolithic Sleeveless Stem and Acetabular Components Devices Used for Hip Replacement Surgery. Smith & Nephew, Inc. Recruiting N/A
100
Trial Size
11.31 11 miles
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors M.D. Anderson Cancer Center Recruiting N/A
24
Trial Size
11.31 11 miles
Open Label Trial Evaluating M7824 (Anti-PD-L1/TGF-Beta TRAP) in a Window Setting in Patients With Stage II-III HER2/Neu Positive (HER2+) Breast Cancer (BC) M.D. Anderson Cancer Center Recruiting
1
Trial Phase
20
Trial Size
11.31 11 miles
Intraoperative Investigation of a Directional Lead and Local Field Potentials for the Optimization of Stimulation Efficacy St. Jude Medical Recruiting N/A
8
Trial Size
11.31 11 miles
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102 Ziopharm Recruiting
1
Trial Phase
18
Trial Size
11.31 11 miles
A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors NeuPharma, Inc. Recruiting
1
Trial Phase
80
Trial Size
11.31 11 miles
PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors Pieris Pharmaceuticals, Inc. Recruiting
1
Trial Phase
70
Trial Size
11.31 11 miles
Pediatric Longitudinal Cohort Study of Chronic Pancreatitis University of Iowa Recruiting N/A
860
Trial Size
11.31 11 miles
ANALYSIS OF PEDIATRIC PATIENTS GIVEN INHALED TRANEXAMIC ACID FOR PULMONARY HEMORRHAGE Baylor College of Medicine Recruiting N/A
20
Trial Size
11.31 11 miles
Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery M.D. Anderson Cancer Center Recruiting N/A
100
Trial Size
11.31 11 miles
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Southwest Oncology Group Recruiting
3
Trial Phase
1273
Trial Size
11.31 11 miles
Clinical Outcome Following Arthroscopic Knee Surgery The University of Texas Health Science Center, Houston Recruiting N/A
2000
Trial Size
11.31 11 miles
Colvera for Detection of Disease Recurrence Clinical Genomics Pathology Recruiting N/A
550
Trial Size
11.31 11 miles
Clinical and Histological Outcomes of Allogenic Amnion Chorion Membrane in the Healing of Free Gingival Graft Donor Site The University of Texas Health Science Center, Houston Recruiting N/A
18
Trial Size
11.31 11 miles
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia Clear Creek Bio, Inc. Recruiting
1
Trial Phase
27
Trial Size
11.31 11 miles
Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study Baylor College of Medicine Recruiting
1
Trial Phase
60
Trial Size
11.31 11 miles
Transdiagnostic CBT for Anxiety VA Office of Research and Development Recruiting
2
Trial Phase
252
Trial Size
11.31 11 miles
Pain Control With Pre-operative Cryoneurolysis Following TKA Fondren Orthopedic Group L.L.P. Recruiting N/A
100
Trial Size
11.31 11 miles
Brief Cognitive Behavioral Therapy for Anxiety Michael Debakey Veterans Affairs Medical Center Recruiting N/A
16
Trial Size
11.31 11 miles
A Treatment Invention for Children With Functional Gastrointestinal Pain Baylor College of Medicine Recruiting N/A
250
Trial Size
11.31 11 miles
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections Duke University Recruiting N/A
400
Trial Size
11.31 11 miles
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer Kymab Limited Recruiting
1
Trial Phase
412
Trial Size
11.31 11 miles
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer M.D. Anderson Cancer Center Recruiting
2
Trial Phase
100
Trial Size
11.31 11 miles
Evaluation of a Novel Neonatal Temperature Monitor William Marsh Rice University Recruiting N/A
70
Trial Size
11.31 11 miles
A Phase 2 Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis Dermira, Inc. Recruiting
2
Trial Phase
60
Trial Size
11.31 11 miles
A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS Cyclacel Pharmaceuticals, Inc. Recruiting
1
Trial Phase
50
Trial Size
11.31 11 miles
Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers M.D. Anderson Cancer Center Recruiting N/A
100
Trial Size
11.31 11 miles
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) Urovant Sciences GmbH Recruiting
3
Trial Phase
1088
Trial Size
11.31 11 miles
Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative University of Alberta Recruiting N/A
250
Trial Size
11.31 11 miles
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-III Non-small Cell Lung Cancer Undergoing Radiotherapy and Their Caregivers M.D. Anderson Cancer Center Recruiting N/A
400
Trial Size
11.31 11 miles
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas M.D. Anderson Cancer Center Recruiting
1
Trial Phase
12
Trial Size
11.31 11 miles
Resting-State Functional MRI in Glioma Patients Before and After Surgery M.D. Anderson Cancer Center Recruiting N/A
30
Trial Size
11.31 11 miles
Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients M.D. Anderson Cancer Center Recruiting N/A
500
Trial Size
11.31 11 miles
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Virginia Commonwealth University Recruiting N/A
650
Trial Size
11.31 11 miles
New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality M.D. Anderson Cancer Center Recruiting N/A
10000
Trial Size
11.31 11 miles
Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients M.D. Anderson Cancer Center Recruiting N/A
30
Trial Size
11.31 11 miles
Non-invasive Marker of Infant Food Intake Baylor College of Medicine Recruiting N/A
40
Trial Size
11.31 11 miles
Substance Abuse Pre-Treatment Screening Study National Institute on Drug Abuse (NIDA) Recruiting N/A
7500
Trial Size
11.33 11 miles
Citalopram for Cocaine Dependence The University of Texas Health Science Center, Houston Recruiting
2
Trial Phase
125
Trial Size
11.33 11 miles
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Center for International Blood and Marrow Transplant Research Recruiting
3
Trial Phase
35000
Trial Size
11.33 11 miles
Acthar on Proteinuria in IgA Nephropathy Patients Baylor College of Medicine Recruiting
4
Trial Phase
26
Trial Size
11.33 11 miles
Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts bioRASI, LLC Recruiting
3
Trial Phase
413
Trial Size
11.33 11 miles
Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors Provectus Pharmaceuticals Available N/A
0
Trial Size
11.98 12 miles
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Forest Laboratories Recruiting
3
Trial Phase
1100
Trial Size
12.20 12 miles
Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types Johnson & Johnson Vision Care, Inc. Recruiting
4
Trial Phase
120
Trial Size
12.64 13 miles
Effect of Ocular Hygiene on Scleral Lens Wear University of Houston Recruiting
1
Trial Phase
24
Trial Size
12.94 13 miles
Control of Myopia Using Novel Spectacle Lens Designs SightGlass Vision, Inc. Recruiting N/A
255
Trial Size
12.94 13 miles
Comparing Acute Aerobic and Resistance Exercise University of Houston Recruiting N/A
63
Trial Size
12.94 13 miles
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis Novartis Recruiting
3
Trial Phase
324
Trial Size
13.50 14 miles
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene Sienna Labs Recruiting
2
Trial Phase
60
Trial Size
13.50 14 miles
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) Menlo Therapeutics Inc. Recruiting
3
Trial Phase
400
Trial Size
13.50 14 miles
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis Menlo Therapeutics Inc. Recruiting
3
Trial Phase
200
Trial Size
13.50 14 miles
Phase 2b Study to Evaluate the Efficacy and Safety of GBR 830 in Adults With Moderate to Severe Atopic Dermatitis Glenmark Pharmaceuticals S.A. Recruiting
2
Trial Phase
392
Trial Size
13.50 14 miles
Phase 2 Safety, Pharmacokinetics and Efficacy Study of CA-008 in Bunionectomy Subjects Concentric Analgesics Recruiting
2
Trial Phase
144
Trial Size
13.50 14 miles
Defocus and Choroidal Thickness University of Houston Recruiting N/A
45
Trial Size
13.50 14 miles
Topical NVN1000 for the Treatment of External Genital and Perianal Warts Novan, Inc. Recruiting
2
Trial Phase
120
Trial Size
16.07 16 miles
Safety and Tolerability of Metronidazole Gel 1.3% Watson Pharmaceuticals Recruiting
4
Trial Phase
60
Trial Size
16.07 16 miles
High Resolution Imaging for Early and Better Detection of Bladder Cancer The University of Texas Health Science Center, Houston Recruiting N/A
100
Trial Size
16.72 17 miles
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer M.D. Anderson Cancer Center Recruiting
2
Trial Phase
42
Trial Size
16.72 17 miles
Compare the Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma (FLINTER) Dr. Reddy's Laboratories Limited Recruiting
3
Trial Phase
284
Trial Size
23.34 23 miles
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
3
Trial Phase
1800
Trial Size
26.37 26 miles
Pancreas Resection With and Without Drains Baylor College of Medicine Recruiting
3
Trial Phase
570
Trial Size
28.07 28 miles
Prometra Post-Approval Study Flowonix Medical Recruiting N/A
400
Trial Size
28.92 29 miles
Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) 3V Biosciences, Inc. Recruiting
2
Trial Phase
117
Trial Size
28.92 29 miles
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma Exact Sciences Corporation Recruiting N/A
1500
Trial Size
32.58 33 miles
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain ObsEva SA Recruiting
3
Trial Phase
450
Trial Size
32.63 33 miles
Low-Intensity Chemotherapy and Blinatumomab in Patients With Philadelphia Chromosome Negative Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) M.D. Anderson Cancer Center Recruiting
2
Trial Phase
44
Trial Size
32.85 33 miles
A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer Luye Pharma Group Ltd. Recruiting
1
Trial Phase
24
Trial Size
51.80 52 miles
Liver, Pancreas and Thyroid Function in Burn Patients The University of Texas Medical Branch, Galveston Recruiting N/A
400
Trial Size
55.31 55 miles
Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda The University of Texas, Galveston Recruiting
2
Trial Phase
100
Trial Size
55.38 55 miles
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor Sera Prognostics, Inc. Recruiting N/A
4000
Trial Size
55.38 55 miles
Efficacy, Safety, and Tolerability of MRG-201 Following Intradermal Injection in Subjects With a History of Keloids miRagen Therapeutics, Inc. Recruiting
2
Trial Phase
12
Trial Size
74.28 74 miles
Fish Oil and HMB Supplementation in COPD Texas A&M University Recruiting N/A
45
Trial Size
77.76 78 miles
PRODIGY Registry in NYHA Class III Heart Failure Patients Endotronix, Inc. Recruiting N/A
250
Trial Size
105.11 105 miles
Study of CVN424 in Healthy Subjects Cerevance Beta, Inc. Recruiting
1
Trial Phase
64
Trial Size
130.27 130 miles
Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response Celgene Recruiting
1
Trial Phase
92
Trial Size
130.27 130 miles
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of mRNA-1944 in Healthy Adults. ModernaTX, Inc. Recruiting
1
Trial Phase
32
Trial Size
130.27 130 miles
A Food-Effect Study of E7386 in Healthy Participants Eisai Inc. Recruiting
1
Trial Phase
16
Trial Size
130.27 130 miles
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. Recruiting
1
Trial Phase
50
Trial Size
132.03 132 miles
Evaluation of the Duration of Therapy for Thrombosis in Children University of Colorado, Denver Recruiting
3
Trial Phase
750
Trial Size
132.33 132 miles
Enhanced Recovery With Liposomal Bupivacaine in Orthognathic Surgery University of Texas at Austin Recruiting
4
Trial Phase
75
Trial Size
132.33 132 miles
Sebacia Postmarket Study of Real-World Use Sebacia, Inc. Recruiting N/A
125
Trial Size
132.45 132 miles
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin Menlo Therapeutics Inc. Recruiting
2
Trial Phase
200
Trial Size
132.45 132 miles
Post Market Study of the 3DKneeâ„¢ With E-plus Insert Encore Medical, L.P. Recruiting N/A
300
Trial Size
134.79 135 miles
The Effect of AAT Training in Smokers University of Texas at Austin Recruiting N/A
50
Trial Size
134.80 135 miles
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes BrainScope Company, Inc. Recruiting N/A
220
Trial Size
134.80 135 miles
YMCA Exercise Intervention for Smoking Cessation Study University of Texas at Austin Recruiting N/A
150
Trial Size
134.80 135 miles
The Impact of Blood Flow Restriction (BFR) on Exercise and Hemodynamic Responses University of Texas at Austin Recruiting N/A
40
Trial Size
134.80 135 miles
An Integrated Self-Management Intervention for Adolescents With Polycystic Ovary Syndrome University of Texas at Austin Recruiting N/A
40
Trial Size
134.80 135 miles
Improving Brain Function After Breast Cancer Study University of Texas at Austin Recruiting N/A
40
Trial Size
134.80 135 miles
Acceptance and Mindfulness for Exercise in Anxiety University of Texas at Austin Recruiting N/A
120
Trial Size
134.80 135 miles
The Impact of a Technology-enabled Decision Aid, for Patients With Hip and Knee Osteoarthritis on Decision Quality, Level of Shared Decision-making, Patient Satisfaction and Magnitude of Limitations University of Texas at Austin Recruiting N/A
250
Trial Size
134.80 135 miles
A Cognitive Self-Management Intervention for Persons With Multiple Sclerosis: Adapting Web-based Technology University of Texas at Austin Recruiting N/A
20
Trial Size
134.89 135 miles
A Phase 2a Study of the Efficacy, Safety and Tolerability of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) KalVista Pharmaceuticals, Ltd. Recruiting
2
Trial Phase
123
Trial Size
135.07 135 miles
Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety University of Texas at Austin Recruiting N/A
40
Trial Size
135.07 135 miles
Efficacy of a Plant-derived Quadrivalent VLP Vaccine in the Elderly Medicago Recruiting
3
Trial Phase
12120
Trial Size
135.07 135 miles
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis Aclaris Therapeutics, Inc. Recruiting
2
Trial Phase
120
Trial Size
137.08 137 miles
Long-Term Safety and Efficacy Study of BMS-986165 in Participants With Systemic Lupus Erythematosus Bristol-Myers Squibb Recruiting
2
Trial Phase
360
Trial Size
137.08 137 miles
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine Sanofi Recruiting
3
Trial Phase
505
Trial Size
137.91 138 miles
Post Approval Study of the Eversense® Continuous Glucose Monitoring Senseonics, Inc. Recruiting N/A
400
Trial Size
137.91 138 miles
Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis Nicox Ophthalmics, Inc. Recruiting
2
Trial Phase
40
Trial Size
137.91 138 miles
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Novartis Recruiting N/A
3600
Trial Size
138.89 139 miles
Pregnancy Registry Trial Novartis Recruiting N/A
500
Trial Size
138.89 139 miles
Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec Diasome Pharmaceuticals Recruiting
2
Trial Phase
60
Trial Size
138.89 139 miles
Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation Walden, Jennifer L., M.D.,P.L.L.C. Recruiting N/A
50
Trial Size
139.66 140 miles
ET-01 in Subjects With Lateral Canthal Lines, LCL-207 Eirion Therapeutics Inc. Recruiting
2
Trial Phase
75
Trial Size
139.66 140 miles
Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH) Enyo Pharma Recruiting
2
Trial Phase
160
Trial Size
139.66 140 miles
Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain Axogen Corporation Recruiting N/A
101
Trial Size
139.66 140 miles
Biotensegrity: Thoracolumbar Fascial Integrity in Chronic Low Back Pain ProloAustin Recruiting N/A
100
Trial Size
139.66 140 miles
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate GlaxoSmithKline Recruiting
3
Trial Phase
1500
Trial Size
141.97 142 miles
Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation Cyberonics, Inc. Recruiting N/A
60
Trial Size
143.20 143 miles
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures GlaxoSmithKline Recruiting
4
Trial Phase
100
Trial Size
143.20 143 miles
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation CareDx Recruiting N/A
300
Trial Size
143.74 144 miles
Triathlon Tritanium Knee Outcomes Study Stryker Orthopaedics Recruiting N/A
500
Trial Size
145.79 146 miles
Efficacy of Human Placental Graft in Diabetic Foot Ulcers StimLabs Recruiting N/A
40
Trial Size
145.79 146 miles
Strep A FIA Field Study, Sofia Quidel Corporation Recruiting N/A
1200
Trial Size
148.02 148 miles
Dry Needling vs Dry Needling With ES in Patients With Neck/Shoulder Pain University of Mary Hardin-Baylor Recruiting N/A
44
Trial Size
148.02 148 miles
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Halozyme Therapeutics Recruiting
2
Trial Phase
237
Trial Size
149.67 150 miles
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery KV Pharmaceutical Company Recruiting
3
Trial Phase
1707
Trial Size
165.07 165 miles
Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects Eisai Inc. Recruiting
1
Trial Phase
50
Trial Size
170.50 170 miles
FX-322 in Sensorineural Hearing Loss Frequency Therapeutics Recruiting
1
Trial Phase
24
Trial Size
170.50 170 miles
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects Emergo Therapeutics, Inc. Recruiting
1
Trial Phase
40
Trial Size
170.50 170 miles
OTO-313 in Subjects With Subjective Tinnitus Otonomy, Inc. Recruiting
1
Trial Phase
58
Trial Size
170.50 170 miles
Techniques to Reduce the Severity and Frequency of Emergent Reactions CHRISTUS Health Recruiting N/A
52
Trial Size
172.81 173 miles
Using Structural Health Monitoring to Improve Diagnosis and Treatment of Low Back Injury in U.S. Service Members- Phase 2 Baylor University Recruiting N/A
90
Trial Size
173.59 174 miles
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity Novo Nordisk A/S Recruiting
1
Trial Phase
60
Trial Size
173.59 174 miles
Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate Celgene Recruiting
1
Trial Phase
60
Trial Size
173.59 174 miles
A Safety and Tolerability Study of RJX Drug Product in Healthy Participants Reven Pharmaceuticals, Inc. Recruiting
1
Trial Phase
76
Trial Size
173.59 174 miles
Microassay and Allergy Skin Prick Test Correlation Study United Allergy Services Recruiting N/A
100
Trial Size
174.81 175 miles
Assessment of an Orthopedic Surgery Rotation on Musculoskeletal Competency in Emergency Medicine Residency Training San Antonio Military Medical Center Recruiting N/A
80
Trial Size
174.93 175 miles
Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout Revive Therapeutics, Ltd. Recruiting
2
Trial Phase
66
Trial Size
174.97 175 miles
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH (Aramcho Galmed Pharmaceuticals Ltd Recruiting
2
Trial Phase
240
Trial Size
174.97 175 miles
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors Exact Sciences Corporation Recruiting N/A
3000
Trial Size
174.97 175 miles
Steady-State Pharmacokinetics of Rifaximin 550 mg Tablets in Healthy and Hepatically Impaired Subjects Valeant Pharmaceuticals International, Inc. Recruiting
4
Trial Phase
18
Trial Size
174.97 175 miles
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis Revance Therapeutics, Inc. Recruiting
2
Trial Phase
150
Trial Size
175.24 175 miles
A Comparison of Manual Physical Therapy and Corticosteroid Injections for Knee Osteoarthritis Madigan Army Medical Center Recruiting N/A
156
Trial Size
175.42 175 miles
Home Study of an Advanced Upper Limb Prosthesis Department of Veterans Affairs Recruiting N/A
75
Trial Size
175.42 175 miles
BFR DISTRAD: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture Repair Brooke Army Medical Center Recruiting N/A
52
Trial Size
175.42 175 miles
Battlefield Acupuncture With Sodium Hyaluronate Injections Brooke Army Medical Center Recruiting N/A
60
Trial Size
175.42 175 miles
The Use of Osteopathic Medical Manipulation to Decrease the Incidence and Severity of Post-Operative Sore Throat Brooke Army Medical Center Recruiting N/A
168
Trial Size
175.42 175 miles
BMAC Nerve Allograft Study Brooke Army Medical Center Recruiting N/A
45
Trial Size
175.42 175 miles
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis Bausch Health Americas, Inc. Recruiting
4
Trial Phase
45
Trial Size
176.83 177 miles
Registry of Avance Nerve Graft Evaluating Utilization and Outcomes for the Reconstruction of Peripheral Nerve Discontinuities AxoGen, Inc Recruiting N/A
500
Trial Size
178.10 178 miles
One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System OTE North America Recruiting N/A
200
Trial Size
178.80 179 miles
Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population Johnson & Johnson Vision Care, Inc. Recruiting N/A
135
Trial Size
178.80 179 miles
Incidence and Factors Associated With the Development and Severity of Oral Mucositis The University of Texas Health Science Center at San Antonio Recruiting N/A
800
Trial Size
179.92 180 miles
S-equol in Women With Triple Negative Breast Cancer The University of Texas Health Science Center at San Antonio Recruiting
0
Trial Phase
45
Trial Size
179.92 180 miles
Hydroxychloroquine + Vorinostat in Advanced Solid Tumors The University of Texas Health Science Center at San Antonio Recruiting
1
Trial Phase
48
Trial Size
179.92 180 miles
The MENDSII Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure Vanderbilt University Recruiting
3
Trial Phase
530
Trial Size
179.92 180 miles
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer The University of Texas Health Science Center at San Antonio Recruiting
2
Trial Phase
76
Trial Size
179.92 180 miles
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour) Advanced Circulatory Systems Recruiting N/A
30
Trial Size
179.92 180 miles
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects The University of Texas Health Science Center at San Antonio Recruiting
2
Trial Phase
60
Trial Size
179.92 180 miles
The Role of TLR4 on Lipid-induced Insulin Resistance The University of Texas Health Science Center at San Antonio Recruiting
2
Trial Phase
20
Trial Size
179.92 180 miles
Artisan Aphakia Lens for the Correction of Aphakia (Secondary) in Adults Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
179.92 180 miles
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors Five Prime Therapeutics, Inc. Recruiting
1
Trial Phase
120
Trial Size
179.92 180 miles
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma ADC Therapeutics SARL Recruiting
1
Trial Phase
90
Trial Size
179.92 180 miles
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Novartis Recruiting
1
Trial Phase
100
Trial Size
179.92 180 miles
A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors Novartis Recruiting
1
Trial Phase
35
Trial Size
179.92 180 miles
Maintaining Suppression of Testosterone With Transdermal Estradiol Gel BHR Pharma, LLC Recruiting
2
Trial Phase
120
Trial Size
179.92 180 miles
Chromosome 18 Clinical Research Center The University of Texas Health Science Center at San Antonio Recruiting N/A
1000
Trial Size
179.92 180 miles
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors ImmunoGen, Inc. Recruiting
1
Trial Phase
205
Trial Size
179.92 180 miles
Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action The University of Texas Health Science Center at San Antonio Recruiting N/A
30
Trial Size
179.92 180 miles
Effect of Cycloset on Glycemic Control When Added to GLP-1 Analogue Therapy The University of Texas Health Science Center at San Antonio Recruiting
4
Trial Phase
30
Trial Size
179.92 180 miles
Health4Kids Intervention Trial for Hispanic Families The University of Texas Health Science Center at San Antonio Recruiting N/A
460
Trial Size
179.92 180 miles
Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab Birdie Biopharmaceuticals HK Limited Recruiting
1
Trial Phase
50
Trial Size
179.92 180 miles
ClariCore System Used in Transrectal Ultrasound Guided Prostate Biopsy for Real-Time Tissue Evaluation Precision Biopsy, Inc. Recruiting N/A
325
Trial Size
179.92 180 miles
FPA150 in Patients With Advanced Solid Tumors Five Prime Therapeutics, Inc. Recruiting
1
Trial Phase
268
Trial Size
179.92 180 miles
Study of ASTX029 in Subjects With Advanced Solid Tumors Astex Pharmaceuticals Recruiting
1
Trial Phase
300
Trial Size
179.92 180 miles
A Trial of Hu5F9-G4 With Avelumab in Ovarian Cancer Forty Seven, Inc. Recruiting
1
Trial Phase
32
Trial Size
179.92 180 miles
Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Regeneron Pharmaceuticals Recruiting
1
Trial Phase
134
Trial Size
179.92 180 miles
VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire) Philips Respironics Recruiting N/A
200
Trial Size
179.92 180 miles
Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants The University of Texas Health Science Center at San Antonio Recruiting N/A
440
Trial Size
179.92 180 miles
Meibomian Gland Dysfunction Management University of the Incarnate Word Recruiting N/A
60
Trial Size
179.92 180 miles
Phase 2 Bunionectomy HTX-011 Administration Study Heron Therapeutics Recruiting
2
Trial Phase
30
Trial Size
179.92 180 miles
Mylan Insulin Aspart Study Mylan Inc. Recruiting
3
Trial Phase
500
Trial Size
179.92 180 miles
Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies Jounce Therapeutics, Inc. Recruiting
1
Trial Phase
40
Trial Size
179.92 180 miles
Phase 3 Efficacy Study of AGN-190584 in Participants With Presbyopia Allergan Recruiting
3
Trial Phase
300
Trial Size
179.92 180 miles
A Phase 1 Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers Zymeworks Inc. Recruiting
1
Trial Phase
69
Trial Size
179.92 180 miles
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors Calithera Biosciences, Inc Recruiting
1
Trial Phase
92
Trial Size
179.92 180 miles
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers Tizona Therapeutics, Inc Recruiting
1
Trial Phase
100
Trial Size
179.92 180 miles
Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2) ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
280
Trial Size
179.92 180 miles
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) Neurotech Pharmaceuticals Recruiting
1
Trial Phase
170
Trial Size
181.89 182 miles
Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) Pfizer Recruiting
3
Trial Phase
720
Trial Size
181.89 182 miles
A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer NatureWise Biotech & Medicals Corporation Recruiting
1
Trial Phase
30
Trial Size
181.89 182 miles
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
187.68 188 miles
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD [Redacted] Recruiting
3
Trial Phase
105
Trial Size
203.50 203 miles
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) Cardiovascular Institute of the South Clinical Research Corporation Recruiting N/A
50
Trial Size
213.76 214 miles
A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label AVEO Pharmaceuticals, Inc. Recruiting
2
Trial Phase
86
Trial Size
214.63 215 miles
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Geno LLC Recruiting
2
Trial Phase
75
Trial Size
216.83 217 miles
The Perioperative Management of Anti-thrombotic Drug Registry University of Texas Southwestern Medical Center Recruiting N/A
12000
Trial Size
219.58 220 miles
Management of Antiplatelet Regimen During Surgical Procedures University of Texas Southwestern Medical Center Recruiting N/A
1492
Trial Size
219.58 220 miles
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Sanofi Recruiting
3
Trial Phase
184
Trial Size
220.67 221 miles
Reducing Chronic Kidney Disease Burden in an Underserved Population Baylor Research Institute Recruiting N/A
140
Trial Size
223.09 223 miles
A Study of NKTR-358 in Participants With Systemic Lupus Erythematosis (SLE) Nektar Therapeutics Recruiting
1
Trial Phase
48
Trial Size
223.94 224 miles
The Natural History of Mucolipidosis Type IV Baylor Research Institute Recruiting N/A
35
Trial Size
224.36 224 miles
A Feasibility Study to Evaluate Skin Cleansing With a Sodium Hypochlorite Wash TopMD Skin Care, Inc. Recruiting N/A
20
Trial Size
224.36 224 miles
Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn) Biomet, Inc. Recruiting
4
Trial Phase
80
Trial Size
224.38 224 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
225.19 225 miles
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients Baylor Research Institute Recruiting
1
Trial Phase
20
Trial Size
225.19 225 miles
A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma Seattle Genetics, Inc. Recruiting
1
Trial Phase
75
Trial Size
225.19 225 miles
Group Lifestyle Balance™ for Individuals With Traumatic Brain Injury (GLB-TBI) Baylor Research Institute Recruiting N/A
66
Trial Size
225.19 225 miles
Improving Sleep Quality During Pregnancy Using an Oral Appliance Texas A&M University Recruiting N/A
20
Trial Size
225.19 225 miles
Problem Solving Training for Care Partners of Adults With Traumatic Brain Injury University of Texas Southwestern Medical Center Recruiting N/A
172
Trial Size
225.19 225 miles
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease Hoffmann-La Roche Recruiting
1
Trial Phase
12
Trial Size
225.43 225 miles
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) Merck Recruiting
2
Trial Phase
1960
Trial Size
226.68 227 miles
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated in the DALF-PS-1016 Study Acorda Therapeutics Recruiting
3
Trial Phase
100
Trial Size
226.68 227 miles
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS Biohaven Pharmaceutical Holding Company Ltd. Recruiting
1
Trial Phase
20
Trial Size
226.68 227 miles
A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations Arog Pharmaceuticals LLC Recruiting
2
Trial Phase
48
Trial Size
227.02 227 miles
Parkinson's Disease Biomarker Program University of Texas Southwestern Medical Center Recruiting N/A
240
Trial Size
227.02 227 miles
Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery University of Texas Southwestern Medical Center Recruiting
1
Trial Phase
50
Trial Size
227.02 227 miles
Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Avid Radiopharmaceuticals Recruiting
2
Trial Phase
1800
Trial Size
227.02 227 miles
Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery University of Texas Southwestern Medical Center Recruiting
1
Trial Phase
45
Trial Size
227.02 227 miles
Mitochondrial Function in Patients With Severe Liver Disease University of Texas Southwestern Medical Center Recruiting N/A
15
Trial Size
227.02 227 miles
Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease University of Miami Recruiting N/A
175
Trial Size
227.02 227 miles
Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities University of Texas Southwestern Medical Center Recruiting
3
Trial Phase
400
Trial Size
227.02 227 miles
Brief Intervention for Suicide Risk Reduction in High Risk Adolescents University of Pittsburgh Recruiting
1
Trial Phase
110
Trial Size
227.02 227 miles
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B University of Pittsburgh Recruiting N/A
300
Trial Size
227.02 227 miles
Rituximab and Belimumab for Lupus Nephritis National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
2
Trial Phase
40
Trial Size
227.02 227 miles
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 GlaxoSmithKline Recruiting
1
Trial Phase
80
Trial Size
227.02 227 miles
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure University of Texas Southwestern Medical Center Recruiting
2
Trial Phase
36
Trial Size
227.02 227 miles
Post Study Continuation of C7 for G1D University of Texas Southwestern Medical Center Available
1
Trial Phase
0
Trial Size
227.02 227 miles
Resilience in Adolescent Development University of Texas Southwestern Medical Center Recruiting N/A
1500
Trial Size
227.02 227 miles
The Use of High Flow Nasal Cannula, Standard Face Mask and Standard Nasal Cannula in Morbidly Obese Patients University of Texas Southwestern Medical Center Recruiting N/A
216
Trial Size
227.02 227 miles
Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares Dartmouth-Hitchcock Medical Center Recruiting
2
Trial Phase
30
Trial Size
227.02 227 miles
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy Hoffmann-La Roche Recruiting
2
Trial Phase
100
Trial Size
227.02 227 miles
Sildenafil Treatment for Mild TBI University of Texas Southwestern Medical Center Recruiting
2
Trial Phase
180
Trial Size
227.02 227 miles
Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome University of Texas Southwestern Medical Center Recruiting
1
Trial Phase
18
Trial Size
227.02 227 miles
SAbR With Oligo-Progressive Renal Cell Cancer. University of Texas Southwestern Medical Center Recruiting
2
Trial Phase
20
Trial Size
227.02 227 miles
GrafixPL PRIME Evaluation Case Study University of Texas Southwestern Medical Center Recruiting
4
Trial Phase
40
Trial Size
227.02 227 miles
Treatment of Persistent Cough in IPF With Inhaled RVT-1601 Respivant Sciences Inc. Recruiting
2
Trial Phase
180
Trial Size
227.02 227 miles
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Columbia University Recruiting N/A
30
Trial Size
227.02 227 miles
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients The University of Texas at Arlington Recruiting
4
Trial Phase
15
Trial Size
227.02 227 miles
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study Vanderbilt University Recruiting
3
Trial Phase
561
Trial Size
227.40 227 miles
The Effects of Viscoelastometry Guided Resuscitation During Burn Excision on Post Resuscitation Infections University of Texas Southwestern Medical Center Recruiting N/A
30
Trial Size
227.40 227 miles
Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration Alcon Research Recruiting
1
Trial Phase
106
Trial Size
228.13 228 miles
LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration Alcon Research Recruiting
2
Trial Phase
70
Trial Size
228.13 228 miles
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) Alcon Research Recruiting
4
Trial Phase
280
Trial Size
228.13 228 miles
Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants Daiichi Sankyo, Inc. Recruiting
1
Trial Phase
36
Trial Size
228.43 228 miles
A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects Genentech, Inc. Recruiting
1
Trial Phase
28
Trial Size
228.43 228 miles
Phase 1 Study to Assess AER-271 in Healthy Subjects Aeromics, Inc. Recruiting
1
Trial Phase
78
Trial Size
228.43 228 miles
FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy and Renally Impaired Subjects Goldfinch Bio, Inc. Recruiting
1
Trial Phase
162
Trial Size
228.43 228 miles
Hypothermia's Impact on Pharmacology Children's Hospital of Philadelphia Recruiting N/A
41
Trial Size
228.69 229 miles
A Study to Assess the Efficacy and Safety of IONIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy Isis Pharmaceuticals Recruiting
3
Trial Phase
117
Trial Size
228.69 229 miles
Effects of Lumbopelvic Manipulation on Neuromuscular Activity of Back & Hip Muscles in Adults With Chronic Low Back Pain Texas Woman's University Recruiting N/A
55
Trial Size
228.69 229 miles
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
3
Trial Phase
320
Trial Size
228.69 229 miles
FARE Peanut SLIT and Early Tolerance Induction University of North Carolina, Chapel Hill Recruiting
2
Trial Phase
50
Trial Size
228.69 229 miles
Heart And Lung Failure - Pediatric INsulin Titration Trial Children's Hospital Boston Recruiting
3
Trial Phase
1414
Trial Size
228.69 229 miles
Sexual Function Trial of Overactive Bladder: Medication Versus PTNS Medstar Health Research Institute Recruiting N/A
312
Trial Size
228.69 229 miles
Treatment of Memory Disorders in Gulf War Illness With High Definition Transcranial Direct Cortical Stimulation The University of Texas at Dallas Recruiting N/A
120
Trial Size
228.69 229 miles
Executive Function Training Intervention for Chronic Traumatic Brain Injury The University of Texas at Dallas Recruiting N/A
100
Trial Size
228.69 229 miles
Effects of Two Different Dry-Needling Techniques for Low Back Pain Texas Woman's University Recruiting N/A
80
Trial Size
228.69 229 miles
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma CASI Pharmaceuticals, Inc. Recruiting
2
Trial Phase
29
Trial Size
230.16 230 miles
Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) Boston Scientific Corporation Recruiting
2
Trial Phase
100
Trial Size
230.16 230 miles
Efficacy and Safety of AAV2-REP1 for the Treatment of Choroideremia Nightstar Therapeutics Recruiting
3
Trial Phase
140
Trial Size
230.16 230 miles
AGN-241751 in the Treatment of Major Depressive Disorder Allergan Recruiting
2
Trial Phase
250
Trial Size
230.16 230 miles
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine University of Texas Southwestern Medical Center Recruiting
4
Trial Phase
30
Trial Size
230.16 230 miles
Use of AAM for Correction of Age Related Volume Deficits in the Face Musculoskeletal Transplant Foundation Recruiting N/A
24
Trial Size
230.16 230 miles
Influence of Early Menopause on Sympathetic Activation and Cardiovascular Function in Older Women University of Texas Southwestern Medical Center Recruiting N/A
20
Trial Size
230.16 230 miles
Safety and Efficacy of Emixustat in Stargardt Disease Acucela Inc. Recruiting
3
Trial Phase
162
Trial Size
230.16 230 miles
Dichoptic Video Treatment for Amblyopia Retina Foundation of the Southwest Recruiting N/A
100
Trial Size
230.16 230 miles
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) ACEA Therapeutics, Inc. Recruiting
1
Trial Phase
32
Trial Size
230.16 230 miles
To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) Gyroscope Therapeutics Recruiting N/A
350
Trial Size
230.16 230 miles
The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial) Texas Retina Associates Recruiting
4
Trial Phase
50
Trial Size
230.16 230 miles
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia National Cancer Institute (NCI) Recruiting
1
Trial Phase
54
Trial Size
230.63 231 miles
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants Janssen Research & Development, LLC Recruiting
2
Trial Phase
440
Trial Size
232.41 232 miles
Collection of Whole Blood Specimens in Pregnant Women Illumina, Inc. Recruiting N/A
5150
Trial Size
232.41 232 miles
Phase 2 Study of an Immunotherapeutic Treatment, DPX-Survivac in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors ImmunoVaccine Technologies, Inc. (IMV Inc.) Recruiting
2
Trial Phase
232
Trial Size
232.41 232 miles
Expanded Access of Vigil in Solid Tumors Gradalis, Inc. Available N/A
0
Trial Size
232.41 232 miles
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors Array BioPharma Recruiting
1
Trial Phase
42
Trial Size
232.41 232 miles
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Baxalta US Inc. Recruiting
2
Trial Phase
90
Trial Size
233.05 233 miles
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies Cook Children's Health Care System Available N/A
0
Trial Size
233.11 233 miles
Non-Invasive Screening for Fetal Aneuploidy Progenity, Inc. Recruiting N/A
340
Trial Size
233.11 233 miles
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer SCRI Development Innovations, LLC Recruiting
2
Trial Phase
46
Trial Size
233.11 233 miles
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma National Cancer Institute (NCI) Recruiting
1
Trial Phase
62
Trial Size
233.11 233 miles
Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children Cook Children's Health Care System Available N/A
0
Trial Size
233.11 233 miles
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome Urovant Sciences GmbH Recruiting
2
Trial Phase
200
Trial Size
234.59 235 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.